On this webinar, Dr. Richard Gliklich, CEO of OM1, discussed the evolving role of big data and cognitive computing in generating real-world evidence for cardiovascular and metabolic diseases. This session explored how innovative methodologies and technologies can be applied to support safety, value, and commercial strategies. Topics covered included:

  • New real-world evidence methodologies and approaches and their application in cardiovascular and metabolic disease research
  • Using real world data in innovative and outcomes-based payment models
  • Applying advanced analytics to identify treatment patterns, disease activity, and at-risk patients, in areas like pre-diabetes or latent vascular disease in research and practice

View the Recording